Orthopedic Biomaterials Market (By Material Type: Polymers, Calcium Phosphate Cement, Composites, Metal, Ceramics and Bioactive Glasses; By Application: Orthobiologics, Orthopedic Implants, Viscosupplementation, Joint Replacement, Bio-resorbable Tissue Fixation; By End User) - Global Market Size, Trends Analysis, Segment Forecasts, Regional Outlook 2024- 2033


The global orthopedic biomaterials market size accounted for USD 21.38 billion in 2023 and is predicted to reach around USD 43.43 billion by 2033, expanding at a CAGR of 7.38% from 2024 to 2033. Increasing demand for orthopedic implants and rising injuries owing to sports and road calamities fuel the growth of the global orthopedic biomaterials market.

Orthopedic Biomaterials Market Size 2024 to 2033

To Access our Exclusive Data Intelligence Tool with 15000+ Database, Visit: Precedence Statistics

Key Takeaways

  • North America dominated the global market with the highest market share of 36.65% in 2023.
  • Asia-Pacific is expected to expand at the largest CAGR between 2024 and 2033.
  • By Material, the ceramics & bioactive glass segment dominated the market in 2023.
  • By Application, the orthopedic implant segment dominated the global orthopedic biomaterials market in 2023.

Orthopedic Biomaterials Market in the U.S. 2024 to 2033

The U.S. orthopedic biomaterials market size was valued at USD 5.50 billion in 2023 and is estimated to reach around USD 11.69 billion by 2033, growing at a CAGR of 7.88% from 2024 to 2033.

U.S. Orthopedic Biomaterials Market Size 2024 to 2033

Geographically, the global orthopedic biomaterials market is segmented into North America, Europe, Asia Pacific, and Middle East & Africa. North America is estimated to top the global market throughout the estimated time period. The growth in North America has been attributed to the increasing prevalence of various orthopedic surgeries. Growing number of patients requiring knee reconstruction or replacement and other orthopedic procedures are likely to enhance the growth of the market in the region. Europe holds the second largest position in the global orthopedic biomaterials market owing to rising research activities and availability of innovative treatments.

Asia Pacific is projected to witness fastest growth rate in the global orthopedic biomaterials market over the forecast period. This growth is owing to increased bone degenerative and disorders in developing nations such as India and China. India and China show robust growth on account of increasing population and subsequent rise in patient population. Growing expenditure on the healthcare and health infrastructure will further propel the growth of the orthopedic biomaterials market in the region. However, lack of knowledge, limited access to medical treatments results in less development in the Middle East and Africa. Nonetheless, gradual upsurge in spending for development of health care centers UAE (United Arab Emirates) may contribute to the growth in the Middle East during years to come.

Orthopedic Biomaterials Market Share, By Region, 2023 (%)

Growth Factors

The damaged bone has been reconstructed by using biomaterials caused by diseases or trauma. High occurrences of musculoskeletal disease will also drive the market growth of orthopedic biomaterials. Furthermore, significant rise in adoption of technologically advanced products and growth of R&D activities will boost the capabilities of orthopedic biomaterials which will in turn drive their demand in the market. Moreover, the orthopedic biomaterials market is driven by rising number of patients on account of growing number of geriatric population, increasing surgeries and growing health awareness among young generation. Rapidly increasing demand for next generation biomaterial products which are customized to meet the requirement of orthopedic procedure will further strengthen the growth of the market worldwide.

The increasing number of chronic diseases across emerging region such as Asia Pacific drives the market growth. The growth of orthopedic biomaterials rapidly increasing in China owing to it’s expanding population and subsequent rise in patient pool. Increasing health awareness and presence of new treatment methods in the region drives the growth of orthopedic biomaterials market. However, decreasing reimbursement for orthopedic implants owing to restricted reimbursement insurances hinders the growth of orthopedic biomaterials market. Moreover, with the emergence of advanced technology the biomaterials are customized to be used in 3D printing techniques may further offers alluring growth prospects for the market in the near future.

According to Census Bureau of United States the geriatric population (people above 65 age) has grown around 1.6 million from year 2014 to 2015. Rapidly increasing trauma incidences caused by fall, sports and accidents are pushing demand for orthopedic biomaterials has been increased. As population engaged in leisure operations and sports activities increases, the rate of accident is also expected to increase.

Orthopedic Biomaterials Market Scope

Report Highlights Details
Market Size in 2023 USD 21.38 Billion
Market Size by 2033 USD 43.43 Billion
Growth Rate from 2024 to 2033 CAGR of 7.38%
Largest Market North America
Fastest Growing Market Asia Pacific
Base Year 2023
Forecast Period 2024 to 2033
Segments Covered Material, Application, End User, Region
Companies Mentioned Acumed, LLC, Medtronic plc, Globus Medical, Inc., Stryker Corporation, Koninklijke DSM N.V., Exactech, Inc., Johnson & Johnson, Zimmer Biomet, Wright Medical Group, Inc., NuVasive, Inc.

 

Material Insights

Based on the type of material the market has been classified into ceramics & bioactive glass, calcium phosphate cement, composites, metal and polymers. The ceramics & bioactive glass segment dominated the market in 2023 as ceramics are widely adopted in repair of hard tissues in multiple procedures. Owing to increasing use of polymer in bone cement as well as load bearing area for entire joint arthroplasties, the polymer segment is also projected to witness significant growth over the forecast period.  These polymers are used in wide range of applications such as diagnostic support, drug delivery systems and useful material for tissue engineering.

Application Insights

Various applications of orthopedic biomaterials include joint orthobiologics, oerhopedic implants, joint replacement/ reconstruction, viscosupplementation along with the absorbable tissue fixation. The orthopedic implant segment dominated the market in 2023 and continuous to dominate the market over the forecast period. According to the American Society of Plastic Surgeons, biomaterials are widely used for plastic surgeries and the increasing demand for plastic surgeries across the globe is further escalate the biomaterials market.

Orthopedic Biomaterials Market Companies

  • Acumed, LLC
  • Medtronic plc
  • Globus Medical, Inc.
  • Stryker Corporation
  • Koninklijke DSM N.V.
  • Exactech, Inc.
  • Johnson & Johnson
  • Zimmer Biomet
  • Wright Medical Group, Inc.
  • NuVasive, Inc.

Segments Covered in the Report

This research report incorporates complete review of the market with the help of broad qualitative and quantitative understandings, and projections regarding the market. This report presents breakdown of marketplace into potential and niche sectors. Further, this research study analyzes market revenue and its growth trend at global, regional, and country from 2021 to 2033. This report includes market segmentation and its revenue estimation by classifying it based on end-use and region as follows:

By Material Outlook

  • Polymers
  • Ceramics & Bioactive Glasses
  • Calcium Phosphate Cement
  • Composites
  • Metal

By Application Outlook

  • Orthobiologics
  • Orthopedic Implants
  • Viscosupplementation
  • Joint Replacement
  • Bio-resorbable Tissue Fixation

By End User

  • Hospitals
  • Orthopedic Clinics
  • Others

By Regional Outlook

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
  • Middle East & Africa
  • Latin America

Frequently Asked Questions

What is the CAGR of orthopedic biomaterials market?
The orthopedic biomaterials market is projected to grow at a CAGR of 7.38%% for estimated period 2024 to 2033.
What is the orthopedic biomaterials market size?
The global orthopedic biomaterials market size is expected to increase USD 43.43 billion by 2033 from USD 21.38 billion in 2023.
Which factors driving the growth of orthopedic biomaterials market?
Increasing demand of orthopedic implants and rising injuries owing to sports and road calamities fuel the growth of global orthopedic biomaterials market. The damaged bone has been reconstructed by using biomaterials caused by diseases or trauma. High occurrences of musculoskeletal disease will also drive the market growth of orthopedic biomaterials. Furthermore, significant rise in adoption of technologically advanced products and growth of R&D activities will boost the capabilities of orthopedic biomaterials which will in turn drive their demand in the market.
Which segment accounted for the largest orthopedic biomaterials market share?
The ceramics & bioactive glass segment dominated the market in 2023 as ceramics are widely adopted in repair of hard tissues in multiple procedures.
Which application segment growing faster in the orthopedic biomaterials market?
The orthopedic implant segment dominated the market in 2023 and continuous to dominate the market over the forecast period.
Which region hit maximum market share in the orthopedic biomaterials market?
The growth in North America has been attributed to the increasing prevalence of various orthopedic surgeries. Growing number of patients requiring knee reconstruction or replacement and other orthopedic procedures are likely to enhance the growth of the market in the region.
Which region is projected to witness fastest growth rate in the orthopedic biomaterials market?
Asia Pacific is projected to witness fastest growth rate in the global orthopedic biomaterials market over the forecast period. This growth is owing to increased bone degenerative and disorders in developing nations such as India and China.

PROCEED TO BUY :

   USD 4900
   USD 3800
   USD 2100
   USD 2100
   USD 7500

ASK FOR SAMPLE

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client

Get a Sample